Journal of Pharmacy Practice
Share

Journal of Pharmacy Practice

New York State Council of Health-System Pharmacists

EDITOR
Henry Cohen, MS, PharmD, FCCM, BCPP, CGP Long Island University, Brooklyn, NY

eISSN: 15311937| ISSN: 08971900|Current volume: 29|Current issue: 3 Frequency: Bi-monthly
The Journal of Pharmacy Practice (JPP) is a peer-reviewed journal that offers practicing pharmacists in-depth useful reviews and research trials and surveys of new drugs and novel therapeutic approaches, pharmacotherapy reviews and controversies, pharmacokinetics, drug interactions, drug administration, adverse drug events, medication safety, pharmacy education, and other pharmacy practice topics. Several issues will be partially dedicated to a pharmacy practice theme such as medication therapy management or drug-induced diseases. Special sections include biomedical informatics reviews, cardiology key articles, and the New York State Council of Health-System Section.


Like the pharmacy profession, topics are diverse. Recent topics have included:

  • Anticoagulation—Treating Thrombosis in Selected Patient Populations
  • Anticoagulation—Dosing, Monitoring, and Adverse Drug Reactions
  • Immunology and Autoimmune Diseases
  • Infectious Diseases in the Critically III
  • Diabetes Management
  • Topics in Internal Medicine
  • Hepatitis
  • Hepatology
  • Cardiovascular Therapeutics
  • Rheumatology

Each peer-reviewed issue assesses practice issues; practice settings; therapeutics issues; disease management; the latest research; current government, legal and regulatory issues; as well as issues arising from today’s topsy-turvy health-care environment. Each issue features a guest editor with particular expertise in the subject area.

**********************************************************************
Journal Aims

Journal of Pharmacy Practice was established in 1988 and is published 6 times per year. The journal is read and cited both nationally and internationally. The objective of the editorial board of the Journal of Pharmacy Practice, as well as that of SAGE Publications, is to offer the practicing pharmacist topical, pertinent, and useful information to support pharmacy practice and medication therapy management, as well as to expand the pharmacist s professional horizons.

Journal of Pharmacy Practice is presented in a focused single-topic, scholarly, peer-review format. Guest editors are selected for particular expertise in the subject area; they then recruit consulting editors and contributors from that practice or topic area and bring the information together in a relevant and timely fashion for the pharmacist audience.

Journal Scope

The readership, like the pharmacy profession, is diverse and so are the topics covered in every issue. Since the walls between pharmacy practice sites remain distinct yet continue to blend in the continuum of care, each pharmacy practitioner needs to be primed on a wide variety of practice essentials, new advents, and future trends. By focusing on a single topic in each issue, the journal provides the reader with a thorough review of that topic written by experienced and accomplished practitioners. Practice issues, practice settings, therapeutics issues, disease management, research, government, legal, and regulatory issues are reviewed in a timely manner. Each issue contains a list of forthcoming topics.

We intend that Journal of Pharmacy Practice will be of practical value to you. It has been used in daily practice as an informational reference and for teaching purposes; the focused, concise information provided saves time in literature review and provides a consolidated source of information and opinion for topics that affect the profession of pharmacy and the patients that pharmacists serve. Each issue will thoroughly review a topic, providing a validating experience for the reader who is familiar with the topic and new applicable knowledge for the reader who is not—validating for the expert, educating for the novice. Every effort has been made to ensure the correct usage of generic and trade names and to verify drug doses. The ultimate responsibility, however, lies with the practitioner. Please convey any errors or comments to the Editor-In-Chief.

Journal Specialty Sections

In addition to the main topic review articles, most issues will contain an Adverse Drug Events Section, Drug Information Section, Pharmacy Experiential Education Section, Law and Ethics in Pharmacy Practice Section, and a Biomedical Communications and Informatics Reviews Section.

The Adverse Drug Events Section will review drug-induced adverse effect case reports, plausible mechanisms, a literature review, and recommendations for management and prevention.

The Drug Information Section will provide the practitioner with comprehensively searched and evidence-based answers to a variety of drug information questions posed by health care professionals. A search strategy by drug information specialists will be provided to the audience.
 
The Pharmacy Education Section will provide contemporary reviews addressing the challenges and innovations associated with providing quality learning experiences for students enrolled in pharmacy experiential education activities. It will offer recommendations/ suggestions for individuals who serve as experiential pharmacy preceptors. Potential topics will be selected by a nationally recognized group of pharmacy practitioners involved in experiential education and will address academic, administrative, and accreditation-related issues.

The Law and Ethics in Pharmacy Practice Section will analyze pharmacy law, statutes and regulations, public policy, and ethical dilemmas as it pertains to pharmacy and health care.
 
The Biomedical Communications and Informatics Reviews Section will thoroughly review new books, journals, drug information resources, and Web sites. Occasionally, research articles, special feature articles, editorials, and commentaries will be published.

New York State Council of Health-system Pharmacists Section
Journal of Pharmacy Practice is the official journal of the New York State Council of Health-system Pharmacists (NYSCHP). The NYSCHP has over 2000 health-system pharmacist members, who belong to any of 10 statewide chapters. The mission of the NYSCHP is to represent its members and advance pharmacy as an essential component of health care. Its educational goal is to provide education and training to elevate the level of pharmacy practice—the Journal of Pharmacy Practice will help to fulfill this goal. Every issue of the journal will have a section devoted to the NYSCHP and will include the President’s Message, Chapter Highlights, Members in the News, special interest articles, and advertising. In every issue, the NYSCHP will continue to serve as the provider for American College of Pharmacy Education (ACPE) continuing education credits in pharmacy practice-related topics.

Journal Submissions

Journal of Pharmacy Practice welcomes submissions for all journal sections including the Adverse Drug Events Section, Drug Information Section, Pharmacy Education Section, Law and Ethics in Pharmacy Practice Section, and Biomedical Communications and Informatics Reviews Section—section editors should be contacted directly for guidelines and submissions. Unsolicited manuscripts including research articles, commentaries, andother reports will also be considered for publication and should be submitted to the Editor-In-Chief.

This journal is a member of the Committee on Publication Ethics (COPE).
 

Journal Aims

Journal of Pharmacy Practice is a peer-reviewed journal that was established in 1988 and is published 6 times per year. The journal is read and cited both nationally and internationally. The objective of the editorial board of the Journal of Pharmacy Practice, as well as that of SAGE Publications, is to offer the practicing pharmacist topical, pertinent, and useful information to support pharmacy practice and medication therapy management, as well as to expand the pharmacist s professional horizons. The Journal of Pharmacy Practice is presented in a focused single-topic, scholarly, peer-review format. Guest editors are selected for particular expertise in the subject area; they then recruit consulting editors and contributors from that practice or topic area and bring the information together in a relevant and timely fashion for the pharmacist audience.

Journal Scope

The readership, like the pharmacy profession, is diverse and so are the topics covered in every issue. Since the walls between pharmacy practice sites remain distinct yet continue to blend in the continuum of care, each pharmacy practitioner needs to be primed on a wide variety of practice essentials, new advents, and future trends. By focusing on a single topic in each issue, the journal provides the reader with a thorough review of that topic written by experienced and accomplished practitioners. Practice issues, practice settings, therapeutics issues, disease management, research, government, legal, and regulatory issues are reviewed in a timely manner. Each issue contains a list of forthcoming topics.

We intend that the Journal of Pharmacy Practice will be of practical value to you. It has been used in daily practice as an informational reference and for teaching purposes; the focused, concise information provided saves time in literature review and provides a consolidated source of information and opinion for topics that affect the profession of pharmacy and the patients that pharmacists serve. Each issue will thoroughly review a topic, providing a validating experience for the reader who is familiar with the topic and new applicable knowledge for the reader who is not—validating for the expert, educating for the novice. Every effort has been made to ensure the correct usage of generic and trade names and to verify drug doses. The ultimate responsibility, however, lies with the practitioner. Please convey any errors or comments to the Editor-In-Chief.

Founding Editor
James T. O'Donnell Rush Medical College, Palatine, IL
Managing and Scientific Editor
Catherine A. Millares-Sipin, Pharm.D., CGP, BCPS, BCACP Touro College of Pharmacy, New York, NY
SECTION EDITORS - Adverse Drug Events Section
Sudha Narayanaswamy, BS, PharmD, BCPP, CGP GNYHA Services, Inc., New York, NY
Roda Plakogiannis, BS, PharmD, BCPS, CLS Long Island University, Brooklyn, NY
Biomedical Communications and Informatics Reviews Section
Cardiology Key Articles
Christopher Ensor, PharmD, BCPS-CV University of Pittsburgh, Pittsburgh, PA
Paul P. Dobesh, PharmD, FCCP, BCPS (AQ - Cardiology) University of Nebraska Medical Center, Omaha, NE
Pharmacy Experiential Education
Joseph M. Brocavich, PharmD St. John's University, Jamaica, NY
Richard O’Brocta Wegmans School of Pharmacy
EDITORIAL BOARD - Ambulatory Care
Valery L. Chu, BS, PharmD Kingsbrook Jewish Medical Center
John M. Conry, PharmD, BCPS, AAHIVP St. John's University, Jamaica, NY
Robert V. DiGregorio, BS, PharmD Long Island University, Brooklyn, NY
Peter Dumo, PharmD Harper University Hospital, Detroit, MI
Cardiology
John Noviasky, PharmD St. Elizabeth Medical Center, Utica, NY
Cynthia A. Sanoski, BS, PharmD, FCCP, BCPS University of the Sciences in Philadelphia, PA
Critical Care
Erkan Hassan, PharmD, FCCM VISICU, Baltimore, MD
Maria I. Rudis, PharmD, DABAT, FCCM University of Southern California, Los Angeles, CA
Drug Information
Michael G. Kendrach, PharmD Samford University, Birmingham, AL
Emergency Medicine
Joseph A. Barone, PharmD Rutgers-The State University of New Jersey, Piscataway, NJ
George Delgado Jr., PharmD University Health Center, Detroit, MI
Christine M. Stork, PharmD University Hospital, Syracuse, NY
Geriatrics
Martin D. Higbee, PharmD University of Arizona, Tucson, AZ
Christine K. O'Neil, PharmD, BCPS, GCP, FCCP Duquesne University, Pittsburgh, PA
Hepatology
Brian A. Hemstreet, PharmD, BCPS University of Colorado, Denver, CO
HIV Disease
Hélène Hardy, PharmD, Msc Boston Medical Center, Boston, MA
Christopher W. James, PharmD Christiana Care Health Services, Wilmington, DE
Infectious Disease
Ben M. Lomaestro, PharmD Albany College of Pharmacy, Albany, NY, USA
Kurt A. Wargo, PharmD, BCPS Auburn University, Auburn, AL
Internal Medicine
Liya Davydov, BCPS, CGP Director, Clinical Pharmacy Services, Innovatix LLC, New York, NY
Nino Marzella, MS, PharmD New York Harbor Healthcare System, Brooklyn, NY
Elizabeth A. Stone, BS, PharmD Good Samaritan Hospital
Toyin Tofade, MS, PharmD, BCPS UNC Eshelman School of Pharmacy
Medication Safety
Elizabeth A. Shlom, PharmD, BCPS GNYHA Services, Inc., New York, NY
Nephrology
Melanie S. Joy, PharmD University of North Carolina, Chapel Hill, NC
Neurology
Jack J. Chen, PharmD, FASCP, FCCP, FCPhA, BCPS, CGP College of Pharmacy, Marshall B. Ketchum University, Fullerton, CA
Melody Ryan, PharmD, MPH University of Kentucky, Lexington, KY, USA
Nuclear Pharmacy
David L. Laven, NPh, CRPh, FASHP, FAPhA Gammascan Consultants, Longwood, FL
Nutritional Support
Bishoy Luka, PharmD, BCNSP Queens Hospital Center, Jamaica, New York
Oncology
Damary Torres, PharmD, BCOP St. John's University, Jamaica, NY
Pediatrics
Kim Benner, PharmD, BCPS, FASHP, FPPAG Samford University, McWhorter School of Pharmacy, Homewood, AL
Ibis D. Lopez, PharmD, BCPS Morgan Stanley Children's Hospital of New York-Presbyterian, NY
Betsy Bickert Poon, PharmD Florida Hospital for Children
Pharmacy Administration
Roy Guharoy, PharmD, MBA, FCP, FCCP, FASHP University of Massachusetts, Worcester, MA
Pharmacy Education
Eric G. Boyce, PharmD University of the Pacific, Stockton, CA, USA
James Colbert, PharmD University of California, San Diego
Janet P. Engle, PharmD, PhD (Hon), FAPhA, FNAP University of Illinois, Chicago, IL
Schwanda Flowers, PharmD University of Arkansas for Medical Sciences
Philip Hritcko, PharmD University of Connecticut, USA
Denise Soltis, RPh Drake University
Thomas Thompson, RPh Hamot Medical Center
Pharmacy Law
Karl G. Williams, RPh, LLM, JD Saint John Fisher College, Rochester, NY
Psychiatry
Michael Biglow, PharmD, BCPS, BCPP Kingsbrook Jewish Medical Center, Brooklyn, NY
Patty Ghazvini, PharmD Florida A&M University, Tallahassee
W. Klugh Kennedy, PharmD, BCPP Mercer University, Macon, GA
Pulmonology
Dennis Williams, PharmD University of North Carolina, Chapel Hill, NC
Rheumatology
Geoffrey C. Wall, PharmD, BCPS, CGP Drake University, Des Moines, IA
International Pharmacy
Christine Mary Clark, BSc, MSc, PhD, FrPharmS Rossendale, Lancashire, UK
Jean G. Dib, BS Pharm, PharmD Dhahran Health Center, Pharmacy Services Division, Kingdom of Saudi Arabia
Laurence A. Goldberg, FRPharmS Hospital Pharmacy Europe, Lancashire, UK
  • Academic Search - Premier
  • Academic Search Alumni Edition
  • CINAHL
  • Clin-Alert
  • EBSCOhost: Academic Search Complete
  • EMBASE/Excerpta Medica
  • InfoTrac (full text)
  • MEDLINE
  • ProQuest: International Pharmaceutical Abstracts
  • PsycINFO
  • Scopus
  • Manuscript Submission Guidelines: Journal of Pharmacy Practice

    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/jpp to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Journal of Pharmacy Practice will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    1. Article types
    2. Editorial policies
        2.1 Peer review policy
        2.2 Authorship
        2.3 Acknowledgements
        2.4 Funding
        2.5 Declaration of conflicting interests
        2.6 Research ethics and patient consent
        2.7 Clinical trials
        2.8 Reporting guidelines
        2.9 Data
    3. Publishing Policies
        3.1 Publication ethics
        3.2 Contributor’s publishing agreement
        3.3 Open access and author archiving
        3.4 Permissions
    4. Preparing your manuscript
        4.1 Word processing formats
        4.2 Artwork, figures and other graphics
        4.3 Supplementary material
        4.4 Reference style 
        4.5 English language editing services
    5. Submitting your manuscript
        5.1 How to submit your manuscript
        5.2 Title, keywords and abstracts
        5.3 Corresponding author contact details
    6. On acceptance and publication
        6.1 SAGE Production
        6.2 Access to your published article
        6.3 Online First publication
    7. Further information

    1. Article types

    (i) Pharmacy Practice Review Articles 
        a. Abstract (250 word limit)
        b. Keywords (5 keywords limit)
        c. References (100 limit) 
        d. Word Count (5,000)
    (ii) Drug or Therapeutic Review Articles 
        a. Abstract (250 word limit)
        b. Keywords (5 keywords limit)
        c. References (150 limit)
        d. Word Count (5,000)
    (iii) Continuing Education Articles 
        a. Abstract (250 word limit)
        b. Keywords (5 keywords limit)
        c. Goals and objectives (7 limit)
        d. References (150 limit)
        e. Word Count (5,000)
    (iv) Research Reports
        a. Structured Abstract (250 word limit) (to include Background, Objective, Methods, Results, Conclusion)
        b. Keywords (5 keywords limit)
        c. References (100 limit)
        d. Word Count (5,000)
    (v) Pharmacy Experiential Education
        a. Abstract (250 word limit)
        b. Keywords (5 keywords limit)
        c. References (100 limit)
        d. Word Count (4,000)
    (vi) Adverse Drug Event Case Reports
        a. Abstract (250 word limit)
        b. Keywords (5 keywords limit)
        c. References (50 limit)
        d. Word Count (2,500)
    (vii) Case Reports or Case Studies
        a. Abstract (250 word limit)
        b. Keywords (5 keywords limit)
        c. References (50 limit)
        d. Word Count (2,500)
    (viii) Biomedical Communications or Informatics Reviews
        a. No Abstract 
        b. Keywords (5 keywords limit)
        c. References (10 limit)
        d. Word Count (1,500)
    (ix) Editorial or Commentary
        a. Abstract (150 word limit)
        b. Keywords (5 keywords limit)
        c. References (20 limit)
        d. Word Count (1,500)
    (x) Letters to the Editor
        a. No Abstract
        b. Keywords (5 keywords limit)
        c. References (10 limit)
        d. Word Count (750)

    2. Editorial policies 

    2.1 Peer review policy
    Journal of Pharmacy Practice adheres to a rigorous double-blind reviewing policy in which the identity of both the reviewer and author are always concealed from both parties.

    2.2 Authorship
    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    (i) Made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published.

    Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
    When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section.

    Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    2.3 Acknowledgements
    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    2.3.1 Writing assistance
    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance”).
    It is not necessary to disclose use of language polishing services.

    Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.

    2.4 Funding
    Journal of Pharmacy Practice requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

    2.5 Declaration of conflicting interests
    It is the policy of Journal of Pharmacy Practice to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    For guidance on conflict of interest statements, please see the ICMJE recommendations here.

    2.6 Research ethics and patient consent
    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    In terms of patient privacy, authors are required to follow the ICMJE Recommendations for the Protection of Research Participants. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

    All research submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    2.7 Clinical trials
    Journal of Pharmacy Practice recommends that authors conform to the ICMJE requirement that clinical trials be registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication.

    2.8 Reporting guidelines
    Journal of Pharmacy Practice recommends that the relevant EQUATOR Network reporting guidelines be followed depending on the type of study.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    2.9 Data
    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Journal of Pharmacy Practice requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor(s) may consider limited embargoes on proprietary data. The editor(s) can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at HCohenLIU@aol.com.

    3. Publishing Policies

    3.1 Publication ethics
    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

    3.1.1 Plagiarism
    Journal of Pharmacy Practice and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.

    3.2 Contributor’s publishing agreement
    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    3.3 Open access and author archiving
    Journal of Pharmacy Practice offers optional open access publishing via the SAGE Choice program. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.

    3.4 Permissions
    Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    4. Preparing your manuscript

    4.1 Word processing formats
    Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout with a minimum of 1 inch margin on all sides of the text. Text should be standard 12 point. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    4.2 Artwork, figures and other graphics
    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.

    Figures supplied in color will appear in color online regardless of whether or not these illustrations are reproduced in color in the printed version. For specifically requested color reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.

    4.3 Supplementary material
    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.

    4.4 Reference style
    References must begin on a separate page. They must be numbered consecutively in the order in which they appear in the text by superscript Arabic numerals. References should be typed in the style adopted by the National Library of Medicine and used in Index Medicus with the exception that only the first 3 authors (last name and up to 2 initials) are listed. For example, a standard journal article with more than 3 authors should be listed as shown below. References should not include any unpublished observations or personal communications.

    1. Schoni MH, Casaulta-Aebischer C, Martinet LV, et al. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr. 2000;19:79-85.

    4.5 English language editing services
    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Checklist:

    1. Provide a letter of transmittal. In this letter, please specify the corresponding author with home address including postal code (ZIP), telephone, beeper, and/or facsimile numbers and an e-mail address.
    2. The entire manuscript must be typed double-spaced in a font size of 12 points on 8.5×11-inch white paper with margins of at least 1 inch all around.
    3. The order of appearance of material in all manuscripts should be as follows: author identification and acknowledgments page, title page, abstract page, text, references, appendixes, tables, figures. Each of these elements should begin on a separate page.
    4. The author identification and acknowledgments page should carry: (1) article title; (2) first name, middle initial, and last name of each author, with highest academic degrees; (3) position title and/or academic title of each author; (4) names of departments and institutions with complete addresses to which each author is affiliated; (5) e-mail addresses of each author; and (6) any acknowledgments, financial disclosure information, and author notes.
    5. The title page should contain an informative descriptive title and no other information.
    6. The abstract page should include an abstract not to exceed 200 words and should include up to 5 keywords.
    7. The main manuscript file should contain no clues as to author identity. Footnotes containing information pertaining to author identity or institutional affiliation should be on the author identification page. The text should have appropriate headings and subheadings. Normally up to 2 headings are used as follows: Headings should appear in all uppercase letters (eg, STUDY METHOD); Subheadings should appear with capitalization followed by lowercase letters (eg, Questionnaire Design).
    8. Generic names (with salt, if applicable) should be used for all drugs. No drug or chemical names should be abbreviated. Trade names are used only to identify that a specific brand was used.
    9. Units and abbreviations: traditional units must be used. Système International (SI) units or other equivalents must appear in parentheses. Gram, gram, Gm, gm must be abbreviated as "g"; cc, ml must be abbreviated as "mL". The words percent or percentage must be spelled when a component of editorial copy. The percent/percentage symbol (%) must be used when indicating potency/strength concentration. Temperatures must be expressed as Celsius/Centigrade; the Fahrenheit equivalent may appear immediately after in parentheses ( ).
    10. A list of symbols used and their meanings must be included if a large number of symbols appears in the text.
    11. References must begin on a separate page. They must be numbered consecutively in the order in which they appear in the text by superscript Arabic numerals. References should be typed in the style adopted by the National Library of Medicine and used in Index Medicus with the exception that only the first 3 authors (last name and up to 2 initials) are listed. For example, a standard journal article with more than 3 authors should be listed as shown below. References should not include any unpublished observations or personal communications.
      1. Schoni MH, Casaulta-Aebischer C, Martinet LV, et al. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr. 2000;19:79-85.
    12. Type each table double-spaced on a separate page. They must be numbered consecutively in the order of their first citation in the text. A brief title for each table must be provided. A table legend must be provided for each table.
    13. Figures should be submitted as graphics files using the original program in which they were created (JPG, TIFF, or EPS; Microsoft Application Files are acceptable for line art). If using scanned images, please be sure the resolution is at least 1200 dpi for line art and 300 dpi for color or grayscale. Drawings must be uniformly sized, if possible, planned for 50% reduction. They must be numbered consecutively in the order of their first citation in the text. A brief title for each figure must be provided. A figure legend must be provided for each figure.
    14. Permission to reproduce previously copyrighted material: The corresponding author is responsible for obtaining written releases from other publishers for SAGE Publications to publish material copyrighted by someone else. If needed, download the Permission to Reprint Form. Complete, date and sign, and submit this form with the manuscript.
    15. Once the manuscript is accepted for publication, the corresponding author will be notified to sign a Journal Contributor Publishing Agreement.

    Proofreading and Reprints: Authors will receive page proofs, which they must correct and return as soon as possible. Authors will also receive a reprint order form.

    Charges for color figures: $800.00 for the first figure and $200.00 for each additional figure. (Color reproduction in the online PDF is free of charge.)

    5. Submitting your manuscript

    5.1 How to submit your manuscript
    Journal of Pharmacy Practice is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/jpp to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    5.2 Title, keywords and abstracts
    Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.

    5.3 Corresponding author contact details
    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    6. On acceptance and publication

    6.1 SAGE Production
    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.

    6.2 Access to your published article
    SAGE provides authors with online access to their final article.

    6.3 Online First publication
    Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication. For more information please visit our Online First Fact Sheet.

    7. Further information
    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Journal of Pharmacy Practice editorial office as follows:
    Henry Cohen, BS, MS, PharmD, BCPP, CGP
    Editor in Chief, The Journal of Pharmacy Practice
    Tel: (718) 604-5373
    Fax: (718) 604-5486
    Beeper: (917) 205-6740
    Email: HCohenLIU@aol.com

    File Downloads:

    Please select a format:

    Individual Subscription, Print Only


    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Backfile Purchase, E-access (Content through 1998)


    Institutional Subscription, Print Only


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Individual, Single Print Issue


    Institutional, Single Print Issue